abstract |
The present invention provides a novel androgen receptor modulator useful for the treatment of cancer such as prostate cancer and hormone-dependent cancer. An imidazolinone compound represented by the following formula (Ia): [A is a pyridine ring; B is a benzene ring; X is O or S; two R 1 together are 1,3-propanediyl and the like; R A is independently —CH 3 , —CF 3 , OCH 3 R 4 is independently H, halogen or the like; R 5 is —OCF 3 or the like; m is 1, 2, 3 or 4; n is 0, 1 or 2. ] [Selection figure] None |